查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1612617

血型分型市场：按技术、测试类型、产品类型和最终用户划分 - 2025-2030 年全球预测

Blood Group Typing Market by Techniques (Assay-Based Techniques, Massively Parallel Sequencing, Microarray), Test Type (ABO Blood Tests, Antibody Screening, Antigen Typing), Product, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年血型鑑定市场价值为33.7亿美元，预计到2024年将达到36.3亿美元，复合年增长率为7.82%，到2030年预计将达到57.2亿美元。

血型是确定个别血型和Rh因子的重要诊断过程，对于安全输血、器官移植和产前护理至关重要。这一步骤对于急诊医学、常规医疗保健和研究至关重要，以确保适合预防潜在危及生命的免疫反应。由于血液安全意识的提高、外科手术数量的增加以及慢性病的流行，血型市场正在扩大，推动了对可靠血液检测的需求。自动和数位打字系统等重大技术进步提高了速度和准确性，这是一个关键驱动因素。此外，新兴国家医疗保健基础设施投资的增加也带来了市场扩张的机会。人口老化和需要输血的疾病增加也增加了市场需求。然而，市场面临先进打字系统的高成本、监管障碍以及对熟练技术人员的需求等挑战。透过开发具有成本效益、易于使用的技术和强大的培训计划来解决这些限制可以促进进一步的成长。就地检验设备、与人工智慧整合进行预测分析以及个人化医疗解决方案等创新代表了有前景的研究领域。此外，加强研发力度以创造通用血液替代品可能会彻底改变该领域。与医疗保健提供者合作，透过教育宣传活动提高意识也可能推动市场成长。相反，挑战包括低收入地区的意识低落、潜在的漏报以及技术复杂性。儘管存在这些障碍，技术创新和扩大医疗保健服务正在推动市场成长。对研发的策略性投资、专注于技术整合的伙伴关係以及利用新兴市场的潜力将是利用血型定型机会的关键。

主要市场统计
基准年[2023] 33.7亿美元
预计年份 [2024] 36.3亿美元
预测年份 [2030] 57.2亿美元
复合年增长率（%） 7.82%

市场动态：揭示快速发展的血型分型市场的关键市场洞察

供需的动态交互作用正在改变血型市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 交通事故、紧急状况和创伤的增加
    • 法医学中越来越多地采用血型分型
    • 严格的输血监管标准
  • 市场限制因素
    • 缺乏意识和熟练的专业人员
  • 市场机会
    • 血型分型系统的进步与发展
    • 增加血型分型的研发活动与产品创新
  • 市场挑战
    • 传输相关风险

波特五力：驾驭血型分型市场的策略工具

波特的五力架构是了解血型分型市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解血型分型市场的外部影响

外部宏观环境因素对血型定型市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解血型定型市场的竞争格局

对血型分型市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵血型分型市场供应商绩效评估

FPNV定位矩阵是评估血型分型市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製血型分型市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对血型分型市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 交通事故、紧急状况和创伤的增加
      • 法医学中越来越多地采用血型分型
      • 严格的输血监管标准
    • 抑制因素
      • 缺乏意识和熟练的专业人员
    • 机会
      • 血型分型系统的进步与发展
      • 加强血型分型研发活动与产品创新
    • 任务
      • 与传染病相关的风险
  • 市场区隔分析
    • 技术：越来越多地采用基于分析的大规模平行定序技术
    • 测试类型：快速出现的ABO血型测试和检测抗原的人类白血球抗原分型测试
    • 产品：血型鑑定服务中耗材和仪器的关键使用
    • 最终使用者：临床实验室和医院血型服务的新用途
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 血型定型市场技术

  • 基于分析的技术
  • 大规模平行定定序
  • 微阵列

第七章依测试类型分類的血型分型市场

  • ABO血型检查
  • 抗体筛检
  • 抗原分型
  • 交叉配系列
  • 人类白血球抗原分型

第八章血型定型市场：副产品

  • 消耗品
  • 装置
  • 服务

第 9 章 血型定型市场：依最终使用者分类

  • 血库
  • 临床实验室
  • 医院

第十章美洲血型鑑定市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区血型分型市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲血型鑑定市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 我的个人健康银行与 Eldon Biologicals A/S 合作，提供结合 POC 血型测试的创新医疗保健解决方案
    • Metropolis Healthcare 开始测试 HSCT 和固态器官移植
    • NHSBT 研究人员发现新血型系统
  • 战略分析和建议

公司名单

  • Agena Bioscience, Inc.
  • Atlas Medical GmbH
  • AXO Science SAS
  • BAG Health Care GmbH
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc
  • Biorex Diagnostics
  • Cardinal Health
  • Genome Diagnostics BV
  • Grifols, SA
  • Hemo bioscience, Inc.
  • Lorne Laboratories Limited
  • Merck KGaA
  • Quotient Suisse SA
  • Rapid Labs Ltd
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-437D459582E9

The Blood Group Typing Market was valued at USD 3.37 billion in 2023, expected to reach USD 3.63 billion in 2024, and is projected to grow at a CAGR of 7.82%, to USD 5.72 billion by 2030.

Blood group typing is a critical diagnostic process that determines an individual's blood type and Rh factor, essential for safe blood transfusions, organ transplants, and prenatal care. This procedure is crucial in medical emergencies, routine healthcare, and research, ensuring compatibility to prevent potentially life-threatening immune responses. The market for blood group typing is expanding due to rising awareness about blood safety, increased surgical procedures, and chronic disease prevalence, which drive the demand for reliable blood testing. Significant technological advancements, such as automated and digital typing systems, enhance speed and accuracy, which are critical growth drivers. Moreover, growing investments in healthcare infrastructure in emerging economies present opportunities for market expansion. The aging population, coupled with increasing cases of disorders requiring blood transfusions, also augments market demand. However, the market faces challenges like high costs of advanced typing systems, regulatory hurdles, and the need for skilled technicians. Addressing these constraints by developing cost-effective, user-friendly technologies and robust training programs could foster further growth. Innovations such as point-of-care testing devices, integration with AI for predictive analytics, and personalized medical solutions represent promising research areas. Additionally, increased R&D efforts towards creating universal blood alternatives could revolutionize the field. Collaborating with healthcare providers to enhance awareness through education campaigns may also promote market growth. Conversely, limited awareness in low-income regions, potential for false negatives, and technical complexities pose challenges. Despite these hurdles, the market is poised for growth, driven by technological innovations and expanding healthcare access. Strategic investments in R&D, partnerships focusing on technological integration, and harnessing emerging market potentials will be key to capitalizing on the opportunities in blood group typing.

KEY MARKET STATISTICS
Base Year [2023] USD 3.37 billion
Estimated Year [2024] USD 3.63 billion
Forecast Year [2030] USD 5.72 billion
CAGR (%) 7.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Group Typing Market

The Blood Group Typing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of road accidents, emergencies, and trauma
    • Rising adoption of blood group typing in forensic sciences
    • Strict regulatory standards regarding blood transfusion
  • Market Restraints
    • Lack of awareness and skilled professional
  • Market Opportunities
    • Advancements and developments in the blood group typing systems
    • Increasing R&D activities and product innovations in blood group typing
  • Market Challenges
    • Risk associated with transmissible diseases

Porter's Five Forces: A Strategic Tool for Navigating the Blood Group Typing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Group Typing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Group Typing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Group Typing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Group Typing Market

A detailed market share analysis in the Blood Group Typing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Group Typing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Group Typing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Group Typing Market

A strategic analysis of the Blood Group Typing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Group Typing Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Atlas Medical GmbH, AXO Science SAS, BAG Health Care GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc, Biorex Diagnostics, Cardinal Health, Genome Diagnostics B.V., Grifols, S.A., Hemo bioscience, Inc., Lorne Laboratories Limited, Merck KGaA, Quotient Suisse SA, Rapid Labs Ltd, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Group Typing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Techniques, market is studied across Assay-Based Techniques, Massively Parallel Sequencing, and Microarray.
  • Based on Test Type, market is studied across ABO Blood Tests, Antibody Screening, Antigen Typing, Cross-Matching Series, and Human Leukocyte Antigen Typing.
  • Based on Product, market is studied across Consumables, Instruments, and Services.
  • Based on End-User, market is studied across Blood Banks, Clinical Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of road accidents, emergencies, and trauma
      • 5.1.1.2. Rising adoption of blood group typing in forensic sciences
      • 5.1.1.3. Strict regulatory standards regarding blood transfusion
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness and skilled professional
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and developments in the blood group typing systems
      • 5.1.3.2. Increasing R&D activities and product innovations in blood group typing
    • 5.1.4. Challenges
      • 5.1.4.1. Risk associated with transmissible diseases
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Techniques: Increasing adoption of assay-based and massively Parallel Sequencing techniques
    • 5.2.2. Test Type: Rapid emergence of ABO blood tests and human leukocyte antigen typing tests to detect the antigens
    • 5.2.3. Product: Significant use of consumables and instruments in blood group typing services
    • 5.2.4. End-User: Emerging use of blood group typing services in clinical laboratories and hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Group Typing Market, by Techniques

  • 6.1. Introduction
  • 6.2. Assay-Based Techniques
  • 6.3. Massively Parallel Sequencing
  • 6.4. Microarray

7. Blood Group Typing Market, by Test Type

  • 7.1. Introduction
  • 7.2. ABO Blood Tests
  • 7.3. Antibody Screening
  • 7.4. Antigen Typing
  • 7.5. Cross-Matching Series
  • 7.6. Human Leukocyte Antigen Typing

8. Blood Group Typing Market, by Product

  • 8.1. Introduction
  • 8.2. Consumables
  • 8.3. Instruments
  • 8.4. Services

9. Blood Group Typing Market, by End-User

  • 9.1. Introduction
  • 9.2. Blood Banks
  • 9.3. Clinical Laboratories
  • 9.4. Hospitals

10. Americas Blood Group Typing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Group Typing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Group Typing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. My Personal Health Bank Joins Forces with Eldon Biologicals A/S for Innovative Healthcare Solutions incorporating POC Blood Typing
    • 13.3.2. Metropolis Healthcare launches test for HSCT & solid organ transplantation
    • 13.3.3. NHSBT Researchers Discover New Blood Group System
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agena Bioscience, Inc.
  • 2. Atlas Medical GmbH
  • 3. AXO Science SAS
  • 4. BAG Health Care GmbH
  • 5. Beckman Coulter, Inc.
  • 6. Bio-Rad Laboratories, Inc
  • 7. Biorex Diagnostics
  • 8. Cardinal Health
  • 9. Genome Diagnostics B.V.
  • 10. Grifols, S.A.
  • 11. Hemo bioscience, Inc.
  • 12. Lorne Laboratories Limited
  • 13. Merck KGaA
  • 14. Quotient Suisse SA
  • 15. Rapid Labs Ltd
  • 16. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. BLOOD GROUP TYPING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GROUP TYPING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GROUP TYPING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD GROUP TYPING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ASSAY-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MASSIVELY PARALLEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ABO BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIGEN TYPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CROSS-MATCHING SERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, 2023